期刊文献+

利用In-Fusion技术构建存活素-增强型绿色荧光蛋白融合基因重组慢病毒表达载体 被引量:4

Value of In-Fusion cloning techhique on routine vector construction
下载PDF
导出
摘要 目的:本研究以构建存活素-增强型绿色荧光蛋白(Survivin&eGFP)融合基因慢病毒表达载体(p-GC-FU-Survivin)为例来探讨In-Fusion克隆技术在常规载体构建中的应用价值。方法:根据In-Fusion技术原理,克隆引物设计时,在Survivin同源序列的两侧分别引入经AgeI线性化的载体p-GCFU两端各15个碱基,将以此引物扩增的聚合酶链式反应(PCR)产物与线性化p-GCFU用In-Fusion交换酶在室温下作用30min,使Sur-vivin特异性扩增产物两端的序列与线性化载体两端的序列发生同源交换,取2μl交换液进行转化,挑取阳性克隆,进行酶切和测序鉴定。将鉴定正确的阳性克隆瞬时转染293T细胞,观察Survivin&eGFP融合蛋白在293T细胞中的表达。结果:每2μl克隆交换液获得大约103个克隆数,阳性率达90%以上,瞬时转染p-GCFU-Survivin可获得Survivin&eGFP融合蛋白在293T细胞中的表达。结论:该技术是一种非连接酶依赖性克隆技术,使基因克隆步骤简化并大大节省了实验时间和经费。 Objective:To introduce a simple method for the cloning of PCR products.Methods:The In-Fusion cloning technique was described by constructing a recombinant lentivirus vector (pGCFU) with surviving & eGFP fusion gene as a sample.The survivin cDNA was amplified with survivin gene-specific primers with 15 bp extensions homologous to the pGCFU ends.By the action of the In-Fusion enzyme at room temperature for 30 minutes,the single-stranded PCR fragment and vector ends were fused due to the 15 bp homology.Finally,clones derived from transformation were chosen randomly and identified.Results:About 103 positive clones for inserts were obtained after transformation with 2 μl of exchanging products,and the ratio of the positive colonies was more than 90%.After 24 h the p-GCFU-survivin was transfected into 293T eukaryotic cells,the expression of the survivin & eGFP fusion gene can be confirmed with fluorescence microscope.Conclusion:The ligation-independent property makes the In-Fusion PCR cloning technique rapid,reliable and higher cost-effective,avoiding the need for multiple sub-cloning steps.
出处 《心血管康复医学杂志》 CAS 2010年第1期10-14,F0003,共6页 Chinese Journal of Cardiovascular Rehabilitation Medicine
基金 福建省自然科学基金资助项目(2006J0095) 福建医科大学附属协和医院重点学科基金资助项目(协院科2005113)
关键词 基因 克隆细胞 基因 病毒 Genes Clone cells Genes viral
  • 相关文献

参考文献8

  • 1Marchuk D,Drumm M, Saulino A, et al. Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products[J]. Nucleic Acids Res, 1991,19(5):1154.
  • 2Ichihara Y, Kurosawa Y. Construction of new T vectors for direct cloning of PeR products [J]. Gene, 1993, 130 (1): 153 -154.
  • 3Tsang TC, Harris DT, Akporiaye ET, et al. Simple method for adapting DNA fragments and PCR products to all of the commonly used restriction sites [J]. Bioteehniques, 1996, 20 (1): 51-52.
  • 4Sabelnikov AG, Avdeeva AV, Ilyashenko. Enhanced uptake of donor DNA by Ca^2+ treated Escherichia coli cells [J]. Mol Gen Genet, 1975, 138 (4): 351-358.
  • 5Benoit RM, Wilhelm RN, Seherer-Beeker D, et al. An improved method for fast, robust, and seamless integration of DNA fragments into multiple plasmids [J]. Protein Expr Purif, 2006, 45 (1): 66-71.
  • 6Berrow NS, Alderton D, Sainsbury S, et al. A versatile ligation-independent cloning method suitable for high-throughput expression screening applications [J]. Nucleic Acids Res, 2007, 35 (6): e45.
  • 7Walhout AJ, Temple GF, Braseh MA, et al. GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes[J]. Methods Enzymol 2000; 328: 575-592.
  • 8Klock HE, White A, Koesema E, et al. Methods and results for semi-automated cloning using integrated robotics[J]. J Struct Funct Genomics, 2005, 6 (2-3): 89-94.

同被引文献61

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部